The burgeoning optimism surrounding classic psychedelics as revolutionary treatments for depression may need a recalibration, as emerging data suggests their…
Read More
Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business
More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…
Read More
What if psilocybin works about as well for depression as an SSRI?
Emerging data from recent studies and meta-analyses suggest that the highly anticipated efficacy of classic psychedelics, particularly psilocybin, in treating…
Read More
Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
The landscape of mental health treatment is on the cusp of a profound transformation, with psilocybin, a compound once relegated…
Read MoreWhat if psilocybin works about as well for depression as an SSRI?
The burgeoning hope surrounding classic psychedelics as a transformative treatment for depression is beginning to confront the sobering realities of…
Read More
Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business
More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…
Read More
What if psilocybin works about as well for depression as an SSRI?
The fervent hope surrounding classic psychedelics as a revolutionary treatment for depression may be tempering, with recent data suggesting that…
Read More
Groundbreaking Study Reveals Psilocybin Reduces Aggression and Activity in Mangrove Rivulus Fish, Opening New Avenues for Neuropsychiatric Research
A pioneering study has demonstrated that psilocybin, the psychoactive compound found in "magic mushrooms," can significantly reduce aggression and activity…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
For decades, successive waves of antidepressants have promised relief to millions suffering from mood disorders, yet the landscape for those…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
For decades, the medical community has grappled with the persistent challenge of mood disorders, offering successive waves of antidepressants that,…
Read More
